All-trans retinoic acid shifts rosiglitazone-induced adipogenic differentiation to osteogenic differentiation in mouse embryonic fibroblasts

Rosiglitazone (RSG) is a potent drug used in the treatment of insulin resistance; however, it is associated with marked skeletal toxicity. RSG-induced osteoporosis may contribute to the promotion of adipogenic differentiation at the expense of osteogenic differentiation in bone marrow stromal cells....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Mol Med
Hlavní autoři: Shao, Ying, Chen, Qian-Zhao, Zeng, Yu-Hua, Li, Yang, Ren, Wen-Yan, Zhou, Lin-Yun, Liu, Rong-Xin, Wu, Ke, Yang, Jun-Qing, Deng, Zhong-Liang, Yu, Yu, Sun, Wen-Juan, He, Bai-Cheng
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5117762/
https://ncbi.nlm.nih.gov/pubmed/27779644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2016.2782
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky